41 peer-reviewed studies · Evidence score: 7.5/10
Jiang Y et al. • Fertility and sterility (2023)
Overall, moderate-quality evidence suggested that progesterone supplementation for LPS was associated with increased LBR and CPR in NC-FET cycles.
Garzón M et al. • Musculoskeletal science & practice (2024)
This review provides limited conclusions about natural history of tendinopathies.
Park H et al. • Frontiers in immunology (2024)
Safety profiles were favorable, with fatigue being the most common adverse event.
Zhou L et al. • BMC endocrine disorders (2023)
Prescription of GLP1RAs improves natural pregnancy rate, menstrual cyclicity and insulin sensitivity, anthropometrics, hormonal indexes in PCOS women.
Grisotto G et al. • Maturitas (2022)
Although some food items were associated with ONM, the overall evidence about associations between diet and ONM remains controversial.
Von Woon E et al. • Human reproduction update (2022)
Measurement of uNK level/activity may be more useful as a diagnostic tool, however, a standardized reference range must be established before this can be of clinical use.
Ozkan H et al. • JAMA network open (2025)
Patient-reported nonmotor outcomes were common after stroke.
Ghobara T et al. • The Cochrane database of systematic reviews (2025)
As the evidence was often of low certainty, and the confidence intervals were wide and therefore consistent with possible benefit and harm, we are uncertain whether one cycle regimen is more effective and safer than another in preparation for FET in subfertile women.
Storman D et al. • The Cochrane database of systematic reviews (2025)
We are very uncertain about whether lurasidone offers benefits to the mental state, total serious adverse events, or severe adverse events when compared to typical antipsychotics for people with schizophrenia.
Antonopoulos AS et al. • European journal of heart failure (2022)
We report the prevalence of ATTR in various population subgroups and provide survival estimates for the natural course of disease and the effects of novel therapeutics.
Shi L et al. • Respiratory care (2020)
This meta-analysis confirmed the significant associations of the presence of bronchiectasis with the natural history, disease course, and outcomes in COPD.
Asatryan B et al. • Circulation. Genomic and precision medicine (2025)
DES cardiomyopathy exhibits heterogeneous phenotypes and a distinct natural history, characterized by high familial penetrance and a substantial MACE burden.
Sossen B et al. • The Lancet. Respiratory medicine (2023)
Reversion from microbiologically positive to undetectable disease in prospective cohorts occurred at an annualised rate of 12% (6·8-18·0).
Liu L et al. • PLoS medicine (2023)
In this study, we observed that stroke survivors with early-onset depression (within 3 months after stroke) are at high risks for remaining depressed and make up two-thirds of the incident cases during 1 year after stroke.
Gibb RD et al. • Journal of the American Association of Nurse Practitioners (2023)
Six studies meeting inclusion criteria were identified (total n = 354).
Ma B et al. • Nutrition research (New York, N.Y.) (2022)
Compared with placebo, astaxanthin significantly reduced blood malondialdehyde concentration (standardized mean difference [SMD]: -0.95; 95% CI, -1.67 to -0.23; P = .01).
Le Glaz A et al. • Journal of medical Internet research (2021)
Machine learning and NLP models have been highly topical issues in medicine in recent years and may be considered a new paradigm in medical research.
Sousa-Pinto B et al. • JAMA surgery (2021)
These findings suggest that most patients with a penicillin allergy history may safely receive cefazolin.
Maleki-Hajiagha A et al. • Journal of ovarian research (2024)
This systematic review shows that AST supplementation may improve assisted reproductive technology outcomes by enhancing oocyte quality and reducing OS in the reproductive organs.
Davinelli S et al. • Marine Drugs (2018)
Astaxanthin supplementation improved skin elasticity, moisture, and reduced wrinkles.